|
Home Court Orders & Endorsements Reports Motion Materials CCAA Proceedings Other Documents & Notices Claims Procedure Service List |
Antibe Therapeutics Inc. - Other Documents & Notices
 First Interim Report of the Receiver- Section 246(2) of the BIA |
November 18, 2024 |
|
The purpose of the first interim report of the Receiver pursuant to section 246(2) of the BIA is to provide information in respect of: (a) Activities undertaken by the Receiver since April 22, 2022; (b) The Receiver's interim statement of receipts and disbursements for the period from April 22, 2024 to October 31, 2024; (c) Details of the property which the Receiver took possession or control that has not yet been sold or realized; (d) Expected recoveries for unsecured creditors; and (e) Information about the anticipated completion of the Receivership. | |
| Fourth Sale Process Letter Update |
November 7, 2024 |
| The Fourth Sale Process Letter Update provides notification that certain milestone dates for the court-approved sale process in respect of Antibe have been extended by seven (7) days at the direction of FTI Consulting Canada Inc. in its capacity as the court-appointed receiver and manager of Antibe. | |
| Third Sale Process Letter Update |
October 16, 2024 |
| The Third Sale Process Letter Update provides notification that certain milestone dates for the court-approved sale process in respect of Antibe have been extended by twenty-two (22) days at the direction of FTI Consulting Canada Inc. in its capacity as the court-appointed receiver and manager of Antibe. | |
| Second Sale Process Letter Update |
September 17, 2024 |
| The Second Sale Process Letter Update provides notification that certain milestone dates for the court-approved sale process in respect of Antibe have been extended by twenty-nine (29) days at the direction of FTI Consulting Canada Inc. in its capacity as the court-appointed receiver and manager of Antibe. | |
| Sale Process Letter Update |
July 29, 2024 |
| The Sale Process Letter Update provides notification that milestone dates for the court-approved sale process in respect of Antibe Therapeutics Inc. ("Antibe") have been extended by fourteen (14) days at the direction of FTI Consulting Canada Inc. in its capacity as the court-appointed receiver and manager of Antibe. | |
| Notice and Statement of the Receiver |
April 30, 2024 |
|
Contact FTI FTI Consulting Useful Links FTI ConsultingOffice of the Superintendent of Bankruptcy Canada |